Novel Ibrutinib Combo Shows High Response Rate... - CLL Support
Novel Ibrutinib Combo Shows High Response Rates in MCL, CLL
Written by
whmk
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
AussieNeilAdministrator
Thanks! Zilo entry now added to healthunlocked.com/cllsuppo...
Anti-ROR-1 drugs are particularly exciting, as they can selectively target CLL cells over healthy B cells.
Neil
Not what you're looking for?
You may also like...
Revisiting Richter transformation in the era of novel CLL agents
will lead to improved treatment and prognosis....